These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 14701814)

  • 1. The preferred pathway of glycosaminoglycan-accelerated inactivation of thrombin by heparin cofactor II.
    Verhamme IM; Bock PE; Jackson CM
    J Biol Chem; 2004 Mar; 279(11):9785-95. PubMed ID: 14701814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sucrose octasulfate selectively accelerates thrombin inactivation by heparin cofactor II.
    Sarilla S; Habib SY; Kravtsov DV; Matafonov A; Gailani D; Verhamme IM
    J Biol Chem; 2010 Mar; 285(11):8278-89. PubMed ID: 20053992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosaminoglycan-binding properties and kinetic characterization of human heparin cofactor II expressed in Escherichia coli.
    Sarilla S; Habib SY; Tollefsen DM; Friedman DB; Arnett DR; Verhamme IM
    Anal Biochem; 2010 Nov; 406(2):166-75. PubMed ID: 20670608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mapping of the thrombin-heparin cofactor II complex.
    Fortenberry YM; Whinna HC; Gentry HR; Myles T; Leung LL; Church FC
    J Biol Chem; 2004 Oct; 279(41):43237-44. PubMed ID: 15292227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent reporters of thrombin, heparin cofactor II, and heparin binding in a ternary complex.
    Verhamme IM
    Anal Biochem; 2012 Feb; 421(2):489-98. PubMed ID: 22206940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibition.
    Mitchell JW; Church FC
    J Biol Chem; 2002 May; 277(22):19823-30. PubMed ID: 11856753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans.
    Sheehan JP; Tollefsen DM; Sadler JE
    J Biol Chem; 1994 Dec; 269(52):32747-51. PubMed ID: 7806495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand.
    Boyle AJ; Roddick LA; Bhakta V; Lambourne MD; Junop MS; Liaw PC; Weitz JI; Sheffield WP
    BMC Biochem; 2013 Mar; 14():6. PubMed ID: 23496873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.
    Liaw PC; Austin RC; Fredenburgh JC; Stafford AR; Weitz JI
    J Biol Chem; 1999 Sep; 274(39):27597-604. PubMed ID: 10488098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.
    Van Deerlin VM; Tollefsen DM
    J Biol Chem; 1991 Oct; 266(30):20223-31. PubMed ID: 1939083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II.
    Blinder MA; Tollefsen DM
    J Biol Chem; 1990 Jan; 265(1):286-91. PubMed ID: 2104620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of glycosaminoglycans with heparin cofactor II.
    Tollefsen DM
    Ann N Y Acad Sci; 1994 Apr; 714():21-31. PubMed ID: 8017769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II.
    Cooper ST; Rezaie AR; Esmon CT; Church FC
    Thromb Res; 2002 Jul; 107(1-2):67-73. PubMed ID: 12413592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serpin-glycosaminoglycan interactions.
    Rein CM; Desai UR; Church FC
    Methods Enzymol; 2011; 501():105-37. PubMed ID: 22078533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes.
    Myles T; Church FC; Whinna HC; Monard D; Stone SR
    J Biol Chem; 1998 Nov; 273(47):31203-8. PubMed ID: 9813026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases.
    Langford-Smith KJ; Mercer J; Petty J; Tylee K; Church H; Roberts J; Moss G; Jones S; Wynn R; Wraith JE; Bigger BW
    J Inherit Metab Dis; 2011 Apr; 34(2):499-508. PubMed ID: 21170681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins.
    Petzelbauer E; Seiffert D; Beckmann R; Pusch B; Geiger M; Binder BR
    Thromb Res; 1992 Jun; 66(5):559-67. PubMed ID: 1381850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide.
    Tollefsen DM
    Adv Exp Med Biol; 1992; 313():167-76. PubMed ID: 1442260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate.
    Ben Mansour M; Dhahri M; Vénisse L; Jandrot-Perrus M; Chaubet F; Maaroufi RM
    Thromb Res; 2009 Apr; 123(6):902-8. PubMed ID: 19046760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand binding to thrombin exosite II induces dissociation of the thrombin-heparin cofactor II(L444R) complex.
    Han JH; Tollefsen DM
    Biochemistry; 1998 Mar; 37(9):3203-9. PubMed ID: 9485475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.